The kratom industry in the United States has grown into a billion-dollar market, despite ongoing debates about its safety and regulatory status. Traditionally used in Southeast Asia for pain relief and energy boosting, kratom has gained popularity in the US for its potential to manage anxiety and opioid withdrawal symptoms.
However, the FDA continues to warn of potential health risks associated with kratom use, citing concerns about liver damage, seizures, and substance use disorder. The legal status of kratom varies by state, with six states banning it entirely and thirteen passing versions of the Kratom Consumer Protection Act.
As the industry expands, researchers emphasize the need for more comprehensive studies to assess kratom’s safety and efficacy. The FDA is currently conducting studies on kratom, but the substance remains in a regulatory grey area, highlighting the complex challenges facing this rapidly growing market.
